Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 6
1997 5
1998 4
2000 1
2002 7
2003 7
2004 4
2005 12
2006 47
2007 72
2008 88
2009 90
2010 81
2011 87
2012 123
2013 98
2014 88
2015 48
2016 53
2017 67
2018 88
2019 104
2020 129
2021 162
2022 134
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

1,205 results
Results by year
Filters applied: . Clear all
Page 1
Intermediate-risk Prostate Cancer: Stratification and Management.
Preisser F, Cooperberg MR, Crook J, Feng F, Graefen M, Karakiewicz PI, Klotz L, Montironi R, Nguyen PL, D'Amico AV. Preisser F, et al. Among authors: karakiewicz pi. Eur Urol Oncol. 2020 Jun;3(3):270-280. doi: 10.1016/j.euo.2020.03.002. Epub 2020 Apr 14. Eur Urol Oncol. 2020. PMID: 32303478 Review.
Systemic therapies for metastatic hormone-sensitive prostate cancer: network meta-analysis.
Mori K, Mostafaei H, Sari Motlagh R, Pradere B, Quhal F, Laukhtina E, Schuettfort VM, Kramer G, Abufaraj M, Karakiewicz PI, Kimura T, Egawa S, Shariat SF. Mori K, et al. Among authors: karakiewicz pi. BJU Int. 2022 Apr;129(4):423-433. doi: 10.1111/bju.15507. Epub 2021 Jul 21. BJU Int. 2022. PMID: 34171173 Free PMC article. Review.
Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.
Mori K, Mostafaei H, Pradere B, Motlagh RS, Quhal F, Laukhtina E, Schuettfort VM, Abufaraj M, Karakiewicz PI, Kimura T, Egawa S, Shariat SF. Mori K, et al. Among authors: karakiewicz pi. Int J Clin Oncol. 2020 Nov;25(11):1892-1900. doi: 10.1007/s10147-020-01777-9. Epub 2020 Sep 14. Int J Clin Oncol. 2020. PMID: 32924096 Free PMC article.
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Tilki D, Graefen M, Kluth LA, Briganti A, Mandel P, Montorsi F, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: karakiewicz pi. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):139-148. doi: 10.1038/s41391-021-00395-4. Epub 2021 May 30. Prostate Cancer Prostatic Dis. 2022. PMID: 34054128 Free PMC article. Review.
Reply by Authors.
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Graefen M, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: karakiewicz pi. J Urol. 2021 Jul;206(1):79. doi: 10.1097/JU.0000000000001695.03. Epub 2021 Apr 6. J Urol. 2021. PMID: 33820427 No abstract available.
Editorial Comment.
Karakiewicz PI. Karakiewicz PI. J Urol. 2019 Sep;202(3):531. doi: 10.1097/01.JU.0000569232.25218.7c. Epub 2019 Aug 8. J Urol. 2019. PMID: 31192750 No abstract available.
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis.
Wenzel M, Würnschimmel C, Nocera L, Collà Ruvolo C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Graefen M, Kluth LA, Roos FC, Mandel P, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: karakiewicz pi. Eur Urol Focus. 2022 Mar;8(2):399-408. doi: 10.1016/j.euf.2021.04.003. Epub 2021 Apr 11. Eur Urol Focus. 2022. PMID: 33853754 Review.
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer.
Chierigo F, Wenzel M, Würnschimmel C, Flammia RS, Horlemann B, Tian Z, Saad F, Chun FKH, Graefen M, Gallucci M, Shariat SF, Mantica G, Borghesi M, Suardi N, Terrone C, Karakiewicz PI. Chierigo F, et al. Among authors: karakiewicz pi. J Urol. 2022 Feb;207(2):375-384. doi: 10.1097/JU.0000000000002250. Epub 2021 Sep 24. J Urol. 2022. PMID: 34555930
1,205 results